VLCAD deficiency . These results suggested the heterogenous nature of the mutations causing the deficiency in the seven patients . Clinically , all patients with VLCAD deficiency exhibited cardiac disease . At least four of them presented with hypertrophic cardiomyopathy . This frequency ( > 57 % ) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants
